Log in
Enquire now
Siolta Therapeutics

Siolta Therapeutics

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.

OverviewStructured DataIssuesContributors

Contents

sioltatherapeutics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Therapeutics
Therapeutics
0
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Diagnosis
Diagnosis
...
Location
San Carlos, California
San Carlos, California
0
San Francisco
San Francisco
B2X
B2C
B2C
B2B
B2B
0
CEO
‌
Nikole Kimes PhD
0
Founder
‌
Susan Lynch PhD
‌
Nikole Kimes PhD
AngelList URL
angel.co/company/si...herapeutics
Date Incorporated
2016
Number of Employees (Ranges)
11 – 500
Email Address
info@sioltatherapeutics.com
Phone Number
+14159910947
Full Address
930 Brittan Ave. San Carlos, CA 940700
Investors
Seventure Partners
Seventure Partners
Founded Date
2016
Total Funding Amount (USD)
30,000,000
Latest Funding Round Date
September 22, 2020
Glassdoor ID
1919526
Latest Funding Type
Series B
Series B
Wellfound ID
siolta-therapeutics
Country
United States
United States

Other attributes

Company Operating Status
Active

Siolta Therapeutics is a privately held, venture-backed biotechnology company based in San Carlos, California. It focuses on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

The company's lead product candidate is a therapeutic developed from gut microbiome for the prevention and treatment of allergic asthma. The product is also being explored for the treatment of other allergic conditions such as seasonal allergy, food allergy, and atopic dermatitis. Phase 1 clinical trials are ongoing for these target conditions. Future plans also include the development of therapeutics for other chronic inflammatory diseases.

Siolta Therapeutics' mission in regards to developing solutions against inflammatory diseases include creating novel microbiome-based medicines and treatments. They are interested in the researching microbiome of infants and promoting immune tolerances for the purpose of preventing and treating inflammatory diseases.

The most genetic information encoded across microbial life occurs in the gut for humans, where various immune cells also reside. When these two life forms interact, microbiome developments occur, which can cause immune dysfunctions. Siolta's goal is to understand the interactions that take place in order to promote healthy developments and prevent dysfunctions.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Siolta Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.